Personalized Neoantigen Vaccine Turns a Patient’s Immune System Into a TCR Discovery Engine
A personalized dendritic cell neoantigen vaccine given to an ovarian cancer patient enabled Swiss researchers to track expanding T-cell clonotypes ...
Tag: Olaparib
Olaparib Plus Radiotherapy Shows Promise for Boosting Immune Defense Against Oral Cancer
A new mouse study finds that combining the PARP inhibitor olaparib with radiotherapy improves tumor control in oral squamous cell ...
Tanshinone IIA Boosts Olaparib Killing Breast Cancer Cells
In a promising advancement for breast cancer therapeutics, researchers have uncovered a potent synergy between Tanshinone IIA, a bioactive compound ...
Groundbreaking Real-World Multicenter Study Reveals First Evidence of Olaparib Maintenance Therapy in Newly Diagnosed Homologous Recombination Deficient Positive/BRCA Wild-Type Ovarian Cancer Patients
Ovarian cancer continues to pose significant challenges in gynecological oncology, particularly regarding its treatment and management strategies. The introduction of ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!